换一批
换一批Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial
作者：
Moreau, Philippe [1]
;
Dimopoulos, Meletios-Athanasios [2]
;
Mikhael, Joseph [3]
;
Yong, Kwee [4]
;
Capra, Marcelo [5]
;
Facon, Thierry [6]
;
Hajek, Roman [7]
;
Spicka, Ivan [8]
;
Baker, Ross [9]
;
Kim, Kihyun [10]
;
Martinez, Gracia [11]
;
Min, Chang-Ki [12]
;
Pour, Ludek [13]
;
Leleu, Xavier [14]
;
Oriol, Albert [15]
;
Koh, Youngil [16]
;
Suzuki, Kenshi [17]
;
Risse, Marie-Laure [18]
;
Asset, Gaelle [19]
;
Mace, Sandrine [20]
;
Martin, Thomas
作者单位：
Murdoch Univ, Perth Blood Inst, Perth, WA, Australia
[1]
CHU, Serv Hematol & Therapie Cellulaire, Poitiers, France
[2]
Hosp Badalona Germans Trias & Pujol, Inst Josep Carreras, Badalona, Spain
[3]
Univ Hosp Ostrava, Dept Hematooncol, Ostrava, Czech Republic
[4]
Catholic Hematol Hosp, Dept Hematol, Seoul, South Korea
[5]
Japanese Red Cross Med Ctr, Myeloma Amyloidosis Ctr, Tokyo, Japan
[6]
Sanofi R&D, Vitry Sur Seine, France
[7]
Natl & Kapodistrian Univ Athens, Athens, Greece
[8]
Lille Univ Hosp, Lille, France
[9]
Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[10]
Univ Hosp Hotel Dieu, Dept Hematol, F-44093 Nantes, France
[11]
Univ Coll Hosp, Dept Haematol, London, England
[12]
Sanofi R&D, Chilly Mazarin, France
[13]
City Hope Canc Ctr, Translat Genom Res Inst, Phoenix, AZ USA
[14]
Univ Calif San Francisco, Dept Hematol, San Francisco, CA 94143 USA
[15]
Univ Hosp Brno, Dept Internal Med Hematol & Oncol, Brno, Czech Republic
[16]
Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
[17]
Hosp Mae de Deus, Ctr Integrado Hematol & Oncol, Porto Alegre, RS, Brazil
[18]
Charles Univ Prague, Dept Med 1, Dept Hematol, Fac Med 1, Prague, Czech Republic
[19]
Sungkyunkwan Univ, Sch Med, Dept Med, Div Hematol Oncol,Samsung Med Ctr, Seoul, South Korea
[20]
发布时间
2021-09-07
- 浏览0
The Lancet
The Lancet
2361-2371页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
